Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Psychedelic Leader to Advance Mental Health in 2021 with Growth of Clinics, Lab and Partnerships

(Image via Numinus Wellness Inc.) In 2020, Health Canada began allowing select patients to take psilocybin for relief of end-of-life-distress. This was followed by a proposed regulation revision that could allow doctors to prescribe both psilocybin and MDMA for t...
Stockhouse Editorial | January 14, 2021 |

XPhyto: Why Rapid PCR Testing is Here to Stay

Regular coronavirus testing is destined to become the norm for many years to come, regardless of how many people get vaccinated against COVID-19. So says Hugh Rogers, the CEO of XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) ( OTC: XPHYF ) , a Canadian life scie...
Marc Davis | April 22, 2021 |

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

The Germans call it COVID-19 “rapid testing mania”. But like most manias, it has opened up a Pandora’s box of problems. As the speed of the vaccine rollout program falters in Europe, on-the-spot antigen testing continues to be the ...
Marc Davis | June 2, 2021 |

PCR Testing: XPhyto Disrupts a Blockbuster Business

It’s the technological evolution that could transform the US $84.4 billion Covid-19 diagnostics market. Vancouver-based life sciences company XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC: XPHYF) expects its rapid Covid-19 test system to be approv...
Marc Davis | February 25, 2021 |

XPhyto: Buyouts, Biosensors and a Booming Business

Test, test, test! It’s the World Health Organization’s battle cry in the global war against COVID-19 and other coronaviruses – including future outbreaks. And it is not getting any less resonant as new variants continue to cause ha...
Marc Davis | August 3, 2021 |

A Golden Opportunity “Out by the Bay”

(Image via Labrador Gold Corp.) Located less than 20 kilometres from Gander in the northeastern part of the island in the province of Newfoundland and Labrador, Labrador Gold Corp’s (LAB) ( TSX: V-LAB , OTC: NKOSF , Forum ) Kingsway prop...
Dave Jackson | November 11, 2020 |

dynaCERT Inc. Set for Meteoric-Like Rise as an ESG Powerhouse

dynaCERT Inc. (TSX: DYA) (OTCQB: DYFSF) (Frankfurt: DMI) recently graduated to trading on the Canadian TSX Big Board. As a condition, prior to listing transition, the TSX exchange required dynaCERT do one capital raise based on a brokered deal (despite the fact the Company ...
Fredrick William | October 2, 2020 |

“Empowering” a New Revolution in Mind, Body and Health Care

When Stockhouse first met up with Empower Clinics Inc . ( CSE.CBDT , OTCQB: EPWCF , Forum ) back in February 2020 , the company was pioneering new technologies in the still-emerging medical cannabis and CBD markets. Fast-forward to today and Empower Clinics has pi...
Dave Jackson | December 15, 2021 |

It Can Take a Lifetime to Build a Good Company, But Only a Minute to Ruin

(Challenger 350 interior image via Bombardier Inc.) Much like that Will Rogers quote that is all too real, even these days … The world is trying to get as close to a “pre-pandemic” norm as it can and nowhere is this movement more evident than i...
Stockhouse Editorial | July 14, 2021 |

Covid-19: Who, what, when, where and why

If there is one thing we know about the coronavirus, it’s that getting a jump on it helps to limit the number of infections. Clearly the best time to stop this, and all outbreaks, is in its early stages. Both China and the United States have been accused of...
Richard (Rick) Mills | April 13, 2020 |
1 2 3 4 5 6 7 8 9 10 ...